Arterosil HP® with MonitumRS® and Vascanox HP® work together as a comprehensive, next-generation approach to vascular health by addressing both structure and function within the circulatory system.

Arterosil HP® is designed to support and restore the endothelial glycocalyx—the delicate, gel-like lining that protects blood vessels and plays a central role in vascular integrity, blood flow regulation, and cellular communication. This often-overlooked layer acts as the interface between the bloodstream and the vessel wall, helping to maintain proper permeability, reduce unwanted adhesion, and support overall cardiovascular resilience. MonitumRS®, the key ingredient in Arterosil HP®, has been shown to help rebuild and protect this critical structure, especially in the presence of environmental, metabolic, and inflammatory stressors that can degrade it over time. Each bottle provides a full 30-day supply at recommended use.

Vascanox HP® complements this structural support by enhancing nitric oxide availability—the primary signaling molecule responsible for vasodilation and healthy circulation. Powered by Calroy’s proprietary Noxa24® blend, Vascanox HP® is formulated to support the body’s natural ability to produce, store, and release nitric oxide over an extended period, with effects lasting up to 24 hours from a single dose. This sustained nitric oxide activity helps promote efficient blood flow, oxygen delivery, and vascular responsiveness, all of which are essential for energy, endurance, and overall cardiovascular performance. Each bottle provides a 1–2 month supply depending on dosing.

Together, Arterosil HP® and Vascanox HP® create a synergistic system that supports both the foundation and function of the vascular network. By restoring the glycocalyx while simultaneously optimizing nitric oxide signaling, this combination addresses multiple pathways involved in circulation, endothelial health, and long-term vascular integrity.